-
Roivant Sciences: Cashing In On Vants And Ventures
24 Apr 2024 20:16 GMT
… , reducing the number of outstanding shares. This followed the $7.1 … fully diluted shares), VantAI, revealed a $674 million collaboration with Bristol-Myers Squibb (BMY …
-
Is this FTSE growth superstar set to soar even higher on new drug results?
24 Apr 2024 06:57 GMT
… (LSE: GSK) has seen its shares rise 25% from their 12 … .4. This is comprised of Bristol-Myers Squibb at 12.4, Merck KGaA … cash flow analysis shows GSK shares to be around 60% undervalued …
-
Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley
07 Mar 2024 20:20 GMT
… superior, positioning it to outperform Bristol-Myers Squibb Co BMY and 2Seventy Bio … durable responses.
Price Action: ACLX shares are down 2.08% at …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by NewEdge Wealth LLC
07 Feb 2024 17:50 GMT
… a new position in shares of Bristol-Myers Squibb in the third quarter … purchased a new position in shares of Bristol-Myers Squibb in the third quarter … ’s leadership believes its shares are undervalued.
Bristol-Myers Squibb Increases Dividend
The business …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by J.P. Morgan Private Wealth Advisors LLC
05 Feb 2024 16:13 GMT
… , October 27th. William Blair downgraded shares of Bristol-Myers Squibb from an “outperform” rating … management believes its shares are undervalued.
Bristol-Myers Squibb Profile
(Free Report)
Bristol-Myers Squibb Company discovers …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Bought by Cornerstone Wealth Management LLC
30 Jan 2024 13:42 GMT
… January 3rd. TheStreet cut shares of Bristol-Myers Squibb from a “b-” rating … 9th. StockNews.com upgraded shares of Bristol-Myers Squibb from a “buy” rating … Finally, Daiwa Capital Markets lowered shares of Bristol-Myers Squibb from an “outperform” rating …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by SageView Advisory Group LLC
24 Jan 2024 16:28 GMT
… Bristol-Myers Squibb news, Director Theodore R. Samuels II acquired 8,500 shares of Bristol-Myers Squibb … Capital Markets downgraded shares of Bristol-Myers Squibb from an “ … Cantor Fitzgerald downgraded shares of Bristol-Myers Squibb from an “overweight …
-
With Shares Trading Near All-Time Highs, Is Now the Time to Take Profits in Novo Nordisk?
22 Mar 2024 15:07 GMT
… the company, and investors sent shares soaring by 53%.
But … to be slowing down -- shares of Novo Nordisk are … Vyndaqel and Vyndamax, Mavacamten from Bristol-Myers Squibb, and Praluent from Sanofi.
… . For this reason, despite shares soaring to new highs, I …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Beacon Investment Advisory Services Inc.
16 Jan 2024 15:54 GMT
… started coverage on shares of Bristol-Myers Squibb in a … Bristol-Myers Squibb
In other Bristol-Myers Squibb news, CEO Christopher S. Boerner bought 3,071 shares … of Bristol-Myers Squibb …
-
Bristol-Myers Squibb (NYSE:BMY) Shares Sold by Lodestar Private Asset Management LLC
16 Jan 2024 15:41 GMT
… . Daiwa Capital Markets lowered shares of Bristol-Myers Squibb from an “outperform” rating … 27th. StockNews.com upgraded shares of Bristol-Myers Squibb from a “buy” rating … 27th. William Blair cut shares of Bristol-Myers Squibb from an “outperform” rating …